Jennifer (Jing-Shan) Hu
Board of Advisors
Dr. Jing-Shan Hu joined Qiming Venture Partners as Venture Partner in March 2016 and as Partner of Qiming US Healthcare Fund. She brings extensive experience in partnering, licensing, business development, R&D and management from three multinational pharmaceutical companies and two US biotech companies.
Before Qiming, Dr. Hu was at Bayer Healthcare Pharmaceuticals as VP and Head of (External) Innovation Center China, responsible for building partnerships for Global Drug Discovery with organizations in Greater China. Prior to that, she was Director of Licensing & External Research at Merck&Co (MSD), heading early stage partnering/licensing efforts in Greater China for Worldwide Licensing & External Research on novel drug candidates and technologies. She had previously worked at Roche Palo Alto as Head of Functional Biology, at Affymetrix as Program Manager of Pharmacogenomics, and at Human Genome Sciences as Scientist of Protein Therapeutics & VEGF-2 Project Leader. While working at biotech companies, she was successful partnering with various organizations in biotech and academia such as Stanford University.
Dr. Hu obtained her post-doctoral training at Harvard Medical School, a Ph.D. from University of Texas Graduate School of Biomedical Sciences at MD Anderson Cancer Center, and a BS in Biochemistry from Peking University in China.